Childhood cancer epidemiology in low‐income countries
暂无分享,去创建一个
Yuri Quintana | Leslie L Robison | Ching-Hon Pui | C. Pui | L. Robison | R. Ribeiro | S. Howard | M. Metzger | J. Wilimas | Raul C Ribeiro | Scott C Howard | Y. Quintana | Monika L Metzger | Judith A Wilimas | Yuri Quintana
[1] W. Mcdougal. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. , 2002, The Journal of urology.
[2] M. Dyer,et al. Use of Preclinical Models to Improve Treatment of Retinoblastoma , 2005, PLoS medicine.
[3] B. Figueiredo,et al. [Childhood adrenocortical tumors]. , 1997, Arquivos brasileiros de endocrinologia e metabologia.
[4] C. Pui,et al. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil , 2007, Pediatric blood & cancer.
[5] P. Boffetta,et al. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation , 2005, Journal of Medical Genetics.
[6] M. Greaves. Infection, immune responses and the aetiology of childhood leukaemia , 2006, Nature Reviews Cancer.
[7] J. Potter,et al. Maternal Diet and Infant Leukemia: The DNA Topoisomerase II Inhibitor Hypothesis: A Report from the Children's Oncology Group , 2005, Cancer Epidemiology Biomarkers & Prevention.
[8] J. Drake,et al. Impact of telemedicine on pediatric neuro‐oncology in a developing country: The Jordanian‐Canadian experience , 2007, Pediatric blood & cancer.
[9] C. Pui,et al. Improving outcomes for children with cancer in low‐income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)‐Part I , 2007, Pediatric blood & cancer.
[10] R. Ribeiro,et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras , 2007, Pediatric blood & cancer.
[11] M. Valsecchi,et al. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements , 2005, Leukemia.
[12] K. Bhatia,et al. Association of Burkitt's Lymphoma with the Epstein-Barr Virus in Two Developing Countries , 2000, Leukemia & lymphoma.
[13] C. Rodríguez-Galindo,et al. Protocol‐based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—Part II , 2007, Pediatric blood & cancer.
[14] L. Robison,et al. Birth Characteristics, Maternal Reproductive History, and the Risk of Infant Leukemia: A Report from the Children's Oncology Group , 2007, Cancer Epidemiology Biomarkers & Prevention.
[15] G. Masera,et al. A survey of resources and activities in the MISPHO family of institutions in Latin America: A comparison of two eras , 2004, Pediatric blood & cancer.
[16] J. Burchenal,et al. Treatment of acute lymphoblastic leukemia. , 1972, Annual review of medicine.
[17] C. Gundy,et al. Influence of Socioeconomic Status on Childhood Acute Lymphoblastic Leukemia Treatment in Indonesia , 2006, Pediatrics.
[18] D. Venzon,et al. Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India. , 1997, Annals of Oncology.
[19] Michael A. Dyer,et al. Inactivation of the p53 pathway in retinoblastoma , 2006, Nature.
[20] N. Laurie,et al. Topotecan combination chemotherapy in two new rodent models of retinoblastoma (Clinical Cancer Research (2005) 11 (7569-7578)) , 2009 .
[21] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[22] M. Relling,et al. Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma , 2005, Clinical Cancer Research.
[23] M. Louw,et al. The 2000 Burkitt lymphoma trial in Malawi , 2005, Pediatric blood & cancer.
[24] L. Clegg,et al. SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia. , 2002, Medical and pediatric oncology.
[25] W. Furlong,et al. Health status and health-related quality of life in survivors of cancer in childhood in Latin America: a MISPHO feasibility study. , 2001, International journal of oncology.
[26] R. Ribeiro,et al. Pediatric Oncology in Countries with Limited Resources , 1997 .
[27] Daniel Sinnett,et al. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. , 2007, Blood.
[28] Yuri Quintana,et al. Implementation of a data management program in a pediatric cancer unit in a low income country , 2007, Pediatric blood & cancer.
[29] C. Pui,et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. , 2004, JAMA.
[30] D. Venzon,et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroid , 2005 .
[31] C. Pui,et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries , 2003, The Lancet.
[32] L. Kinlen. Infections and immune factors in cancer: the role of epidemiology , 2004, Oncogene.
[33] C. Pui,et al. Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop , 2004, Leukemia.
[34] K. Naresh,et al. Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] S. Kayed,et al. The incidence of childhood cancer in Jordan: a population-based study. , 2003, Annals of Saudi medicine.
[36] C. Rodríguez-Galindo,et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] G. Morgan,et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.
[38] D. Campana,et al. Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central America , 2005, Leukemia.
[39] R. W. Miller. Epidemiologic evidence for genetic variability in the frequency of cancer: ethnic differences. , 1988, Basic life sciences.
[40] D. Venzon,et al. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] Miller Rw. Geographical and ethnic differences in the occurrence of childhood cancer. , 1988 .
[42] M. Relling,et al. TOPOISOMERASE II INHIBITOR‐RELATED ACUTE MYELOID LEUKAEMIA , 2000, British journal of haematology.
[43] M. Dyer,et al. The first knockout mouse model of retinoblastoma. , 2006, Cell cycle.
[44] I. Magrath. Non‐Hodgkin's Lymphomas: Epidemiology and Treatment , 1997, Annals of the New York Academy of Sciences.
[45] P. Forgeron,et al. Pediatric pain prevalence and parents' attitudes at a cancer hospital in Jordan. , 2006, Journal of pain and symptom management.
[46] F. Carrión,et al. Establishment of a pediatric HSCT program in a public hospital in Chile , 2006, Pediatric blood & cancer.
[47] D. Parkin,et al. The international incidence of childhood cancer , 1988, IARC scientific publications.
[48] D. Venzon,et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]. , 2005, European journal of cancer.
[49] P. Luthert,et al. Outcome of retinoblastoma in east Africa , 2008, Pediatric blood & cancer.
[50] F. Berrino,et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[52] R. Ribeiro,et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer , 2002, Nature Structural Biology.